ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P13285


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name LMP2_EBVB9
Primary accession number P13285
Secondary accession numbers Q777H4 Q8AZK9
Integrated into Swiss-Prot on January 1, 1990
Sequence was last modified on January 1, 1990 (Sequence version 1)
Annotations were last modified on    June 16, 2009 (Entry version 59)
Name and origin of the protein
Protein name Latent membrane protein 2
Synonym Terminal protein
Gene name
Name: LMP2
From
Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4) [TaxID: 10377] 
Taxonomy Viruses; dsDNA viruses, no RNA stage; Herpesvirales; Herpesviridae; Gammaherpesvirinae; Lymphocryptovirus.
Virus host Homo sapiens (Human) [TaxID: 9606]
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=2840285 [NCBI, ExPASy, EBI, Israel, Japan]
Laux G., Perricaudet M., Farrell P.J.;
"A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome.";
EMBO J. 7:769-774(1988).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LMP2A AND LMP2B).
PubMed=2536113 [NCBI, ExPASy, EBI, Israel, Japan]
Sample J., Liebowitz D., Kieff E.;
"Two related Epstein-Barr virus membrane proteins are encoded by separate genes.";
J. Virol. 63:933-937(1989).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORM LMP2A).
DOI=10.1038/310207a0; PubMed=6087149 [NCBI, ExPASy, EBI, Israel, Japan]
Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J., Gibson T.J., Hatfull G., Hudson G.S., Satchwell S.C., Seguin C., Tuffnell P.S., Barrell B.G.;
"DNA sequence and expression of the B95-8 Epstein-Barr virus genome.";
Nature 310:207-211(1984).
[4]
PHOSPHORYLATION.
PubMed=1710288 [NCBI, ExPASy, EBI, Israel, Japan]
Longnecker R., Druker B., Roberts T.M., Kieff E.;
"An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.";
J. Virol. 65:3681-3692(1991).
[5]
FUNCTION.
DOI=10.1073/pnas.91.2.772; PubMed=8290598 [NCBI, ExPASy, EBI, Israel, Japan]
Miller C.L., Lee J.H., Kieff E., Longnecker R.;
"An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.";
Proc. Natl. Acad. Sci. U.S.A. 91:772-776(1994).
[6]
INTERACTION WITH HUMAN SYK AND LYN.
DOI=10.1016/S1074-7613(95)80040-9; PubMed=7895172 [NCBI, ExPASy, EBI, Israel, Japan]
Miller C.L., Burkhardt A.L., Lee J.H., Stealey B., Longnecker R., Bolen J.B., Kieff E.;
"Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases.";
Immunity 2:155-166(1995).
[7]
MUTAGENESIS OF TYR-74; TYR-85 AND TYR-112.
PubMed=9733815 [NCBI, ExPASy, EBI, Israel, Japan]
Fruehling S., Swart R., Dolwick K.M., Kremmer E., Longnecker R.;
"Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.";
J. Virol. 72:7796-7806(1998).
[8]
FUNCTION.
DOI=10.1016/S1074-7613(00)80623-8; PubMed=9768760 [NCBI, ExPASy, EBI, Israel, Japan]
Caldwell R.G., Wilson J.B., Anderson S.J., Longnecker R.;
"Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.";
Immunity 9:405-411(1998).
[9]
INTERACTION WITH HUMAN ITCH AND NEDD4L.
DOI=10.1128/MCB.20.22.8526-8535.2000; PubMed=11046148 [NCBI, ExPASy, EBI, Israel, Japan]
Winberg G., Matskova L., Chen F., Plant P., Rotin D., Gish G., Ingham R., Ernberg I., Pawson T.;
"Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases.";
Mol. Cell. Biol. 20:8526-8535(2000).
[10]
SUBCELLULAR LOCATION.
DOI=10.1016/S1074-7613(01)00089-9; PubMed=11163230 [NCBI, ExPASy, EBI, Israel, Japan]
Dykstra M.L., Longnecker R., Pierce S.K.;
"Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR.";
Immunity 14:57-67(2001).
[11]
SUBCELLULAR LOCATION.
PubMed=11961256 [NCBI, ExPASy, EBI, Israel, Japan]
Lynch D.T., Zimmerman J.S., Rowe D.T.;
"Epstein-Barr virus latent membrane protein 2B (LMP2B) co-localizes with LMP2A in perinuclear regions in transiently transfected cells.";
J. Gen. Virol. 83:1025-1035(2002).
[12]
UBIQUITINATION.
DOI=10.1006/viro.2002.1562; PubMed=12202215 [NCBI, ExPASy, EBI, Israel, Japan]
Ikeda M., Ikeda A., Longnecker R.;
"Lysine-independent ubiquitination of Epstein-Barr virus LMP2A.";
Virology 300:153-159(2002).
[13]
X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 236-244.
DOI=10.1074/jbc.M410807200; PubMed=15537660 [NCBI, ExPASy, EBI, Israel, Japan]
Fiorillo M.T., Ruckert C., Hulsmeyer M., Sorrentino R., Saenger W., Ziegler A., Uchanska-Ziegler B.;
"Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes.";
J. Biol. Chem. 280:2962-2971(2005).
Comments
  • FUNCTION: Isoform LMP2A maintains EBV latent infection of B-lymphocyte, by preventing lytic reactivation of the virus in response to surface immunoglobulin (sIg) cross-linking. Acts like a dominant negative inhibitor of the sIg-associated protein tyrosine kinases, LYN and SYK. Also blocks translocation of the B-cell antigen receptor (BCR) into lipid rafts, preventing the subsequent signaling and accelerated internalization of the BCR upon BCR cross-linking. Serves as a molecular scaffold to recruit SYK, LYN and E3 protein-ubiquitin ligases, such as ITCH and NEDD4L, leading to ubiquitination and potential degradation of both tyrosines kinases. Possesses a constitutive signaling activity in non-transformed cells, inducing bypass of normal B lymphocyte developmental checkpoints allowing immunoglobulin-negative cells to colonize peripheral lymphoid organs.
  • FUNCTION: Isoform LMP2B may be a negative regulator of isoform LMP2A.
  • SUBUNIT: Isoform LMP2A cytoplasmic N-terminal domain interacts with human SRC family protein tyrosine kinases SYK and LYN. Binds human ITCH, WWP2 and NEDD4L.
  • SUBCELLULAR LOCATION: Isoform LMP2A: Host cell membrane; Multi-pass membrane protein. Note=Isoform LMP2A is localized in plasma membrane lipid rafts.
  • SUBCELLULAR LOCATION: Isoform LMP2B: Host endomembrane system; Multi-pass membrane protein. Host cytoplasm, host perinuclear region. Note=Isoform LMP2B localizes to perinuclear regions.
  • ALTERNATIVE PRODUCTS: 2 named isoforms [FASTA] produced by alternative splicing.
    NameLMP2A
    SynonymsTP1
    Isoform IDP13285-1
    This is the isoform sequence displayed in this entry.
    NameLMP2B
    SynonymsTP2
    Isoform IDP13285-2
    Features which should be applied to build the isoform sequence: VSP_016139.
  • PTM: Isoform LMP2A is phosphorylated on cytoplasmic N-terminal tyrosines residues, possibly by human LYN.
  • PTM: Can be ubiquitinated at by human ITCH and WWP2 on the N-terminus in a lysine-independent manner.
  • MISCELLANEOUS: In healthy individuals, EBV typically establishes a persistent latent infection in which the virus can be detected in resting, nonproliferating peripheral B-lymphocytes. These latently infected cells express only 2 virally encoded genes, LMP2A and EBNA1.
  • SIMILARITY: Belongs to the herpesviridae LMP-2 family.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
M24212; AAA45887.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
Y00835; CAA68762.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
V01555; -; NOT_ANNOTATED_CDS; Genomic_DNA.[EMBL / GenBank / DDBJ]
AJ507799; CAD53383.1; ALT_SEQ; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AJ507799; CAD53382.1; ALT_SEQ; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR A30178; WMBELM.
3D structure databases
PDB
1UXS; X-ray; 1.55 A; C=236-244.[ExPASy / RCSB / EBI]
1UXW; X-ray; 1.71 A; C=236-244.[ExPASy / RCSB / EBI]
2JO9; NMR; -; B=54-62.[ExPASy / RCSB / EBI]
3BVN; X-ray; 2.55 A; C/F=236-244.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1UXS; -.
1UXW; -.
2JO9; -.
3BVN; -.
ModBase P13285.
Ontologies
GO
GO:0005737; Cellular component: cytoplasm (inferred from electronic annotation from UniProtKB-KW).
GO:0030430; Cellular component: host cell cytoplasm (inferred from electronic annotation from UniProtKB-SubCell).
GO:0016021; Cellular component: integral to membrane (inferred from electronic annotation from UniProtKB-KW).
GO:0005886; Cellular component: plasma membrane (inferred from electronic annotation from UniProtKB-KW).
GO:0044419; Biological process: interspecies interaction between organisms (inferred from electronic annotation from UniProtKB-KW).
QuickGo view.
Family and domain databases
InterPro IPR010881; Herpes_LMP2.
Graphical view of domain structure.
Pfam PF07415; Herpes_LMP2; 1.
Pfam graphical view of domain structure.
Other
ProtoNet P13285.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Alternative splicing; Cell membrane; Complete proteome; Cytoplasm; Host-virus interaction; Membrane; Phosphoprotein; Transmembrane; Ubl conjugation.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
CHAIN   1   497  497     Latent membrane protein 2. PRO_0000116280
TOPO_DOM   1   123  123     Cytoplasmic (Potential). 
TRANSMEM   124   144  21     Potential. 
TOPO_DOM   145   147  3     Extracellular (Potential). 
TRANSMEM   148   168  21     Potential. 
TOPO_DOM   169   177  9     Cytoplasmic (Potential). 
TRANSMEM   178   198  21     Potential. 
TOPO_DOM   199   211  13     Extracellular (Potential). 
TRANSMEM   212   232  21     Potential. 
TOPO_DOM   233   241  9     Cytoplasmic (Potential). 
TRANSMEM   242   262  21     Potential. 
TOPO_DOM   263   267  5     Extracellular (Potential). 
TRANSMEM   268   288  21     Potential. 
TOPO_DOM   289   296  8     Cytoplasmic (Potential). 
TRANSMEM   297   317  21     Potential. 
TOPO_DOM   318   318  1     Extracellular (Potential). 
TRANSMEM   319   339  21     Potential. 
TOPO_DOM   340   354  15     Cytoplasmic (Potential). 
TRANSMEM   355   375  21     Potential. 
TOPO_DOM   376   388  13     Extracellular (Potential). 
TRANSMEM   389   409  21     Potential. 
TOPO_DOM   410   422  13     Cytoplasmic (Potential). 
TRANSMEM   423   443  21     Potential. 
TOPO_DOM   444   449  6     Extracellular (Potential). 
TRANSMEM   450   470  21     Potential. 
TOPO_DOM   471   497  27     Cytoplasmic (Potential). 
MOTIF   97   101  5     PPPPY WW-binding. 
MOD_RES   112   112        Phosphotyrosine; by host (Potential). 
VAR_SEQ   1   119        Missing (in isoform LMP2B). VSP_016139
MUTAGEN   74    74        Y->F: Loss of interaction with human SYK. 
MUTAGEN   85    85        Y->F: Loss of interaction with human SYK. 
MUTAGEN   112   112        Y->F: Complete loss of phosphorylation. 
Sequence information
Length: 497 AA [This is the length of the unprocessed precursor] Molecular weight: 53011 Da [This is the MW of the unprocessed precursor] CRC64: F4DC9BB3C1FD83F1 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MGSLEMVPMG AGPPSPGGDP DGYDGGNNSQ YPSASGSSGN TPTPPNDEER ESNEEPPPPY 

        70         80         90        100        110        120 
EDPYWGNGDR HSDYQPLGTQ DQSLYLGLQH DGNDGLPPPP YSPRDDSSQH IYEEAGRGSM 

       130        140        150        160        170        180 
NPVCLPVIVA PYLFWLAAIA ASCFTASVST VVTATGLALS LLLLAAVASS YAAAQRKLLT 

       190        200        210        220        230        240 
PVTVLTAVVT FFAICLTWRI EDPPFNSLLF ALLAAAGGLQ GIYVLVMLVL LILAYRRRWR 

       250        260        270        280        290        300 
RLTVCGGIMF LACVLVLIVD AVLQLSPLLG AVTVVSMTLL LLAFVLWLSS PGGLGTLGAA 

       310        320        330        340        350        360 
LLTLAAALAL LASLILGTLN LTTMFLLMLL WTLVVLLICS SCSSCPLSKI LLARLFLYAL 

       370        380        390        400        410        420 
ALLLLASALI AGGSILQTNF KSLSSTEFIP NLFCMLLLIV AGILFILAIL TEWGSGNRTY 

       430        440        450        460        470        480 
GPVFMCLGGL LTMVAGAVWL TVMSNTLLSA WILTAGFLIF LIGFALFGVI RCCRYCCYYC 

       490 
LTLESEERPP TPYRNTV 

P13285 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!